SciELO - Scientific Electronic Library Online

 
vol.74 número3Biomarcadores basados en tecnologías ómicas: estado actual y su potencial uso en la clínicaProteómica: una herramienta para desarrollar nuevos métodos de diagnóstico y descifrar mecanismos moleculares de enfermedades pediátricas índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Boletín médico del Hospital Infantil de México

versión impresa ISSN 1665-1146

Resumen

AGUIRRE-GUILLEN, William Alejandro et al. Omics techniques and biobanks to find new biomarkers for the early detection of acute lymphoblastic leukemia in middle-income countries: a perspective from Mexico. Bol. Med. Hosp. Infant. Mex. [online]. 2017, vol.74, n.3, pp.227-232. ISSN 1665-1146.  https://doi.org/10.1016/j.bmhimx.2017.03.007.

Acute lymphoblastic leukemia (ALL) affects the quality of life of many children in the world and particularly in Mexico, where a high incidence has been reported. With a proper financial investment and with well-organized institutions caring for those patients, together with solid platforms to perform high-throughput analyses, we propose the creation of a Mexican repository system of serum and cells from bone marrow and blood samples derived from tissues of pediatric patients with ALL diagnosis. This resource, in combination with omics technologies, particularly proteomics and metabolomics, would allow longitudinal studies, offering an opportunity to design and apply personalized ALL treatments. Importantly, it would accelerate the development of translational science and will lead us to further discoveries, including the identification of new biomarkers for the early detection of leukemia.

Palabras llave : Acute lymphoblastic leukemia; Omics techniques; Biobanks.

        · resumen en Español     · texto en Inglés     · Inglés ( pdf )